Very good point ,

The newer HAART are with some less side effects but still they have some severe ,

I think lot will depend on how many side effects insurances will see , and how much money they will spend on it.

This is a business as many others , so bottom line what will give probably final decision..

And now will depend , if they lose some patients with HIV because of price , will they make many times over with cancers ...

All IMO of course !!!!